Author:
Howell M.,Wang C.,Mahmoud A.,Hellermann G.,Mohapatra S. S.,Mohapatra S.
Publisher
Springer Science and Business Media LLC
Reference113 articles.
1. Organization WH. Prevention and control of chronic respiratory diseases in low and middle-income African countries: A Preliminary Report 2002.
2. Organization WH. Action plan of the Global Alliance against Chronic Respiratory diseases, 2008–20132008.
3. Swai H, Semete B, Kalombo L, Chelule P, Kisich K, Sievers B. Nanomedicine for respiratory diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(3):255–63. doi: 10.1002/wnan.33 .
4. Ranjita S, Loaye AS, Khalil M. Present status of nanoparticle research for treatment of tuberculosis. J Pharm Pharm Sci. 2011;14(1):100–16.
5. Crotty S, Cameron C, Andino R. Ribavirin’s antiviral mechanism of action: lethal mutagenesis? J Mol Med (Berl). 2002;80(2):86–95. doi: 10.1007/s00109-001-0308-0 .
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献